|1.||Volkov, V P: 2 articles (01/2011 - 01/2009)|
|2.||Abdullaev, T A: 1 article (01/2012)|
|3.||Kurbanov, R D: 1 article (01/2012)|
|4.||Mardanov, B U: 1 article (01/2012)|
|5.||Mirzarakhimova, S T: 1 article (01/2012)|
01/01/2012 - "PCMP compared with idiopathic cardiomyopathy is characterized by less pronounced dilation of left cardiac chambers, relative preservation of left ventricular contractile function, more favorable course of CHF with lower frequency of destabilizations of clinical state. "
01/01/2011 - "These data confirm the advisability of regarding PCMP as a separate nosological entity in the group of seconfary cardiomyopathies."
01/01/2012 - "Results of the study of special characteristics of the course of chronic heart failure (CHF) in women with periportal cardiomyopathy (PCMP) are presented. "
01/01/2011 - "Ten most common and clinically significant pathological changes of ECG in schizophrenic patients with and without phenothiazine-induced cardiomyopathy (PCMP) at different stages of neuroleptic therapy are considered. "
01/01/2009 - "It is concluded that phenothiazine-induced dilatation cardiomyopathy should be regarded as a separate nosological form belonging to a group of secondary DCMPs and designated as PCMP."
|3.||Virus Diseases (Viral Diseases)
|4.||Schizophrenia (Dementia Praecox)
01/01/2009 - "Analysis of the patients" medical histories, dynamics of clinical conditions, and results of electrocardiography did not show significant differences between patients with schizophrenia and PCMP compared with mentally healthy DCPM subjects DCMP. "
01/01/2009 - "The author considers selected clinical and morphological characteristics of secondary dilatation cardiomyopathy in patients with schizophrenia after long-term treatment with phenotiazine neuroleptics for the purpose of substantiating nosological self-sufficiency of this pathology (PCMP). "
|2.||Antipsychotic Agents (Antipsychotics)
|4.||Deoxycytidine Monophosphate (DCMP)